The Department of Veterans Affairs National Acquisition Center awarded an indefinite delivery contract to Seqirus USA Inc. to deliver influenza virus vaccines for the 2022-2023 season to the VA, Federal Bureau of Prisons, Indian Health Service, and James A. Lovell Federal Health Care Center. Task orders under the contract, with a potential value of $69,190,924.13, provide vaccines including 10-dose vials, single dose syringes in boxes of 10, and an adjuvant vaccine for individuals aged 65 and older. Places of performance encompass U.S., Philippines, and Puerto Rico facilities.
The original pre-solicitation notice aimed to procure approximately 12,000 10-dose vials for VA, 2,500 vials for BOP, 9,905 vials for IHS, 180,000 boxes of 10 pre-filled syringes for VA, and other quantities. The solicitation was issued by the VA National Acquisition Center to supply vaccines between August 15 and October 15, 2022 to government agencies. As the prime contractor, Seqirus USA Inc. leverages its expertise and infrastructure to ensure the VA, BOP, IHS and James A. Lovell Federal Health Care Center can meet preventative healthcare needs by protecting at-risk populations from influenza through the 2022-2023 season.
Generated 1/4/24, 11:23 PM